Table 5 |
|||
|
Adverse events |
|||
|
Item |
Placebo |
Aquamin |
Total |
|
|
|||
|
Number subjects treated |
14 |
8 |
22 |
|
Total number of adverse events |
21 |
10 |
31 |
|
-upper respiratory events |
3 |
2 |
5 |
|
-gastrointestinal events |
4 |
1 |
5 |
|
-food reaction |
0 |
1 |
1 |
|
-hypertension/cardiovascular |
1 |
1 |
2 |
|
-musculoskeletal events |
4 |
3 |
7 |
|
-neurological events |
2 |
0 |
2 |
|
-increased OA pain |
7 |
2 |
9 |
|
|
|||
|
Frestedt et al. Nutrition Journal 2009 8:7 doi:10.1186/1475-2891-8-7 |
|||
